Experience: Kristin’s practice includes the clearance, enforcement and exploitation of brand names, proceedings before the Trademark Trial and Appeal Board, domain name dispute resolution, licensing matters including trademark, copyright, brand management, and entertainment related arrangements, and litigation support for intellectual property and entertainment-related claims. Kristin is also involved in the intellectual property and commercial aspects of various corporate transactions and assists a variety of well-established and start-up companies. In addition to her extensive work regarding trademarks and domain names, Kristin has experience preparing and prosecuting patent applications in various types of subject matter, including wearable devices, innovative mechanical apparatus, beauty products, cosmetics, hair preparations, nutritional items, and biotechnology.
Kristin advises domestic and international clients in various industries such as health and wellness, entertainment, finance, fashion, restaurant services, luxury goods, vitamin and nutritional supplements, cosmetics, toys, new media, computer games, software, and industrial products.
Seton Hall University School of Law, J.D.
Drew University, B.A., magna cum laude, Biology
“Branding and the Metaverse,” NY Law Journal (March 25, 2022).
“Creative Branding and Maximizing Intellectual Property Protection With Color,” NY Law Journal (Fashion Law Supplement) (August 27, 2021).
“Tips and Pitfalls of UDRP Proceedings,” New Matter, a publication of the Intellectual Property Section of the California Bar Association, Volume 44, No. 3 (Sept. 2019).
“Intellectual Property and the Fashion Resale Market: Drawing the Line Between Rights Holders and Resellers,” NY Law Journal (Fashion Law Supplement) (August 23, 2019).
“Fashion and Apparel Licensing,” Chapter in Fashion Law: A Guide for Designers, Fashion Executives, and Attorneys, pp. 81-104 (2009) (Barbara Kolsun, Kristin B. Kosinski)
“Hatch-Waxman in the Federal Courts: 1994-2004,” Drug Development and Industrial Pharmacy, 31(2): 15-22 (2005) (S. Peter Ludwig, Kristin B. Kosinski)
“Generic Drug Approval: Post 1984; Hatch-Waxman Reform,” Chapter in Introduction to the Pharmaceutical Regulatory Process, I. Berry, Editor (2005) (S. Peter Ludwig, Marc Gross, Atul Singh, Kristin B. Kosinski)
“Patents and Polymorphs” Chapter in Biotechnology and Pharmaceutical Law 2004: Patents and Business Strategies, Practicing Law Institute Intellectual Property Course Handbook Series (S. Peter Ludwig, Kristin B. Kosinski)
“Playing by the Orange Book Listing Rules in View of Recent Hatch-Waxman Reforms,” Food Drug L. Reg. and Educ. 10 (2004)
“Research Tool Patents and the Section 271(e)(1) Exemption,” Chapter in Biotechnology Law 2003: Biotechnology Patents & Business Strategies, Practicing Law Institute Intellectual Property Course Handbook Series (Robert C. Sullivan, Kristin B. Kosinski)
Discovering Drugs in Patent File Histories, Food Drug L. Reg. and Educ. 12 (2003)
The Hatch-Waxman Act: Balancing Competing Interests or Survival of the Fittest? 52 Food Drug L. J. 247 (2002)
Cancellation of the Washington Redskins’ Federal Trademark Registrations: Should Sports Team Names, Mascots, and Logos Contain Native American Symbolism? 10 Seton Hall J. Sports L. 289 (2000)
U.S. Patent and Trademark Office
U.S. Court of Appeals for the Ninth Circuit
U.S. District Court for the Central District of California
U.S. District Court for the Southern District of California
New York Bar
New Jersey Bar